The Osteoarticular Manifestations in Patients With Gitelman Syndrome

Last updated: April 3, 2025
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Arthritis And Arthritic Pain (Pediatric)

Osteoarthritis

Kidney Failure (Pediatric)

Treatment

conventional radiograph or computed tomography

Clinical Study ID

NCT06922370
2021-0670
  • All Genders

Study Summary

Patients with clinically and genetically confirmed Gitelman Syndrome are screened for CPPD, and the clinical and radiographic manifestations are collected and analyzed.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patients confirmed with Gitelman Syndrome

Exclusion

Exclusion Criteria:

  • Patients with other confounding situations such as Bartter Syndrome,hyperparathyroidism

Study Design

Total Participants: 120
Treatment Group(s): 1
Primary Treatment: conventional radiograph or computed tomography
Phase:
Study Start date:
November 01, 2021
Estimated Completion Date:
December 01, 2025

Study Description

Patients with clinically and genetically confirmed Gitelman Syndrome are screened for calcium pyrophosphate deposition, and the clinical data and radiographic manifestations are collected and analyzed to investigate the osteoarticular features in patients with Gitelman Syndrome.

Connect with a study center

  • the second affiliated hospital, Zhejiang University School of medicine

    Hangzhou, Zhejiang 310005
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.